Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Shandong Pharmaceutical Glass CoSHSE:600529 -0.31%92 5-Year Yield-on-Cost % is 5.80 as of Aug. 26, 2026, which is 135% above its 10-year median of 2.47. GuruFocus rates SHSE:600529 with a GF Score™ of 92/100 and a GF Value™ of ¥23.45 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 241 Packaging & Containers companies, Shandong Pharmaceutical Glass Co ranks better than 76.76% on this metric.
The historical rank and industry rank for Shandong Pharmaceutical Glass Co's 5-Year Yield-on-Cost % or its related term are showing as below:
SHSE:600529'
s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0.99 Med: 2.47 Max: 10.58
Current: 5.8
During the past 13 years, Shandong Pharmaceutical Glass Co's highest Yield on Cost was 10.58. The lowest was 0.99. And the median was 2.47.
SHSE:600529's 5-Year Yield-on-Cost % is ranked better than 76.76% of 241
companies
in the Packaging & Containers industry
Industry Median: 3.06
vs SHSE:600529: 5.80
Shandong Pharmaceutical Glass Co (SHSE:600529) 5-Year Yield-on-Cost % Explanation
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
Shandong Pharmaceutical Glass Co 5-Year Yield-on-Cost % Related Terms
SHSE:600529 vs SW, PKG, IP: 5-Year Yield-on-Cost % Comparison
For the Packaging & Containers subindustry, Shandong Pharmaceutical Glass Co's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shandong Pharmaceutical Glass Co 5-Year Yield-on-Cost % vs Packaging & Containers Industry
For the Packaging & Containers industry and Consumer Cyclical sector, Shandong Pharmaceutical Glass Co's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where Shandong Pharmaceutical Glass Co's 5-Year Yield-on-Cost % falls into.
Shandong Pharmaceutical Glass Co 5-Year Yield-on-Cost % Calculation
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
Shandong Pharmaceutical Glass Co (SHSE:600529) has a 5-Year Yield-on-Cost % of 5.80 as of Aug. 26, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Shandong Pharmaceutical Glass Co and its competitors. This is 135% above median its historical median of 2.47. Over the past decade, Shandong Pharmaceutical Glass Co's 5-Year Yield-on-Cost % has ranged from 0.99 to 10.58. According to the industry distribution chart, Shandong Pharmaceutical Glass Co ranks #56 out of 241 companies in the Packaging & Containers industry, placing it in the top 23.2%.
Is Shandong Pharmaceutical Glass Co's 5-Year Yield-on-Cost % too high?
Shandong Pharmaceutical Glass Co's current 5-Year Yield-on-Cost % of 5.80 is 135% above median its 10-year median of 2.47. Over the past 10 years, this metric has ranged from a low of 0.99 to a high of 10.58. The Packaging & Containers industry median 5-Year Yield-on-Cost % is 3.06. Shandong Pharmaceutical Glass Co's value of 5.80 is 89.5% above this industry median. Based on the distribution chart, Shandong Pharmaceutical Glass Co ranks #56 out of 241 companies in the Packaging & Containers industry, which is in the top quartile — a strong position relative to peers. Overall, Shandong Pharmaceutical Glass Co has a GF Score™ of 92/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Shandong Pharmaceutical Glass Co's 5-Year Yield-on-Cost % compare to SW and PKG?
According to the Packaging & Containers industry distribution chart, Shandong Pharmaceutical Glass Co ranks #56 out of 241 companies for 5-Year Yield-on-Cost %. This places Shandong Pharmaceutical Glass Co in the top 23% of its industry — outperforming the majority of peers. The industry median 5-Year Yield-on-Cost % is 3.06. Shandong Pharmaceutical Glass Co's value of 5.80 is 89.5% above this benchmark. Historically, Shandong Pharmaceutical Glass Co's own 5-Year Yield-on-Cost % has ranged from 0.99 to 10.58 over the past decade. While the company's 10-year median is 2.47 vs. the industry median of 3.06, Shandong Pharmaceutical Glass Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Packaging & Containers company?
The median 5-Year Yield-on-Cost % among Packaging & Containers companies is 3.06, based on 241 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shandong Pharmaceutical Glass Co's current 5-Year Yield-on-Cost % of 5.80 is 89.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Shandong Pharmaceutical Glass Co and its competitors. For the Packaging & Containers industry, the median 5-Year Yield-on-Cost % is 3.06 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shandong Pharmaceutical Glass Co's current 5-Year Yield-on-Cost % is 5.80, which is 135% above median its own 10-year median of 2.47. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shandong Pharmaceutical Glass Co stock overvalued right now?
Based on GuruFocus' analysis, Shandong Pharmaceutical Glass Co (SHSE:600529) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥23.45, compared to a current price of ¥19.16 — trading 18.3% below its estimated fair value. The current 5-Year Yield-on-Cost % is 5.80, which is 135% above median its 10-year median of 2.47 and 89.5% above the Packaging & Containers industry median of 3.06. Shandong Pharmaceutical Glass Co's overall GF Score™ is 92/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Shandong Pharmaceutical Glass Co (SHSE:600529), the current 5-Year Yield-on-Cost % is 5.80 as of Aug. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Shandong Pharmaceutical Glass Co (SHSE:600529) Overvalued in 2026?
Based on GuruFocus' analysis, Shandong Pharmaceutical Glass Co stock appears to be undervalued.
The current stock price of ¥19.16 is trading 18.3% below its estimated GF Value™ of ¥23.45.
GuruFocus considers Shandong Pharmaceutical Glass Co to be Modestly Undervalued.
Key valuation signals for SHSE:600529:
5-Year Yield-on-Cost %: 5.80 (135% above median its 10-year median of 2.47)
GF Value™: ¥23.45 vs. price of ¥19.16 (18.3% below fair value)
Industry Position: 89.5% above the Packaging & Containers median (#56 of 241)
No single metric tells the full story. See the SHSE:600529 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Shandong Pharmaceutical Glass Co Ltd is a pharmaceutical glass packaging product company. Its pharmaceutical glass packaging products and butyl rubber series products which service object of pharmaceutical, food, daily necessities industries. The products include for moulded injection vial for antibiotics series, tubular glass vial series, amber glass bottle series, neutral borosilicate glass bottle series, infusion bottle series, cosmetic bottles series, food bottles series, butyl rubber stopper series, prefillable syringes series, and aluminum-plastic cap series.
92GF Score
Get the complete analysis for SHSE:600529
5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:600529 has been successfully added to your 
